HMS
TARS icon

Hanseatic Management Services’s Tarsus Pharmaceuticals TARS Stock Holding History

Hanseatic Management Services’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$7.7K Buy
+139
New +$6.31K 0.01% 98

Other funds holding TARS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Hanseatic Management Services's TARS Position: Q4 2024 in Review

Hanseatic Management Services opened a new position in Tarsus Pharmaceuticals (TARS) in Q4 2024: 139 shares worth $7.7K. The stake represents 0.01% of the portfolio and ranks #98 among its holdings.

195 funds tracked by Wall St. Rank hold TARS as of Q4 2024.

  • Hanseatic Management Services held 139 shares of Tarsus Pharmaceuticals worth $7.7K as of Q4 2024.
  • Tarsus Pharmaceuticals was a new Hanseatic Management Services position in Q4 2024.
  • Tarsus Pharmaceuticals made up 0.01% of Hanseatic Management Services's portfolio in Q4 2024, its #98 holding.
  • 195 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q4 2024.

Based on Hanseatic Management Services's 13F filing for Q4 2024, filed 15 Jan 2025.